$125.00
250mcg Total Active Mass – Oral Capsules
SLU-PP-332 Capsules 250mcg is an advanced, high-purity oral small-molecule exercise-mimetic formulation engineered to study selective ERRα/ERRγ nuclear receptor agonism, accelerated lipid beta-oxidation, and mitochondrial biogenesis. By leveraging an ultra-stable structure that resists gastrointestinal degradation to upregulate PGC-1α transcription, shift skeletal muscle fibers toward oxidative Type I characteristics, and drive white adipose browning kinetics, this precisely standardized 250mcg capsule presentation stands as a premier investigative tool for tracking non-shivering thermogenesis, resting metabolic acceleration, and lean tissue preservation in laboratory models.
Supplied as stable, precisely standardized 250mcg research capsules. Restricted strictly to laboratory and in vitro evaluation.
Eterna Peptides presents premium-grade SLU-PP-332 Capsules (250mcg), an advanced oral small-molecule research formulation engineered to study target-specific metabolic mimicry, enhanced mitochondrial bioenergetics, and skeletal muscle tissue repartitioning. Functioning as a specialized non-hormonal compound, SLU-PP-332 acts as a potent, dual-selective agonist targeting Estrogen-Related Receptors (ERR). Structured inside a precisely standardized 250mcg per-capsule presentation, this unique configuration serves as a premier investigative tool for tracking white adipose tissue browning kinetics, accelerated lipid beta-oxidation, and non-shivering thermogenesis without requiring systemic physical exertion models.
### Advanced 250mcg Oral Stability Profile
Unlike traditional macromolecular peptides that face severe enzymatic breakdown in the gastrointestinal tract, the small-molecule architecture of SLU-PP-332 is engineered for robust stability across varying gastric pH environments. Upon oral administration, it effortlessly traverses the intestinal epithelial barrier to achieve clean systemic bioavailability without requiring specialized nanocarrier encapsulation. This precise 250mcg presentation allows researchers to evaluate tight steady-state daily exposure baselines, track micro-dose kinetic mapping, and observe metabolic saturation thresholds over extended longitudinal laboratory models.
### Mechanism of Action
The SLU-PP-332 matrix targets vital cellular, nuclear, and enzymatic checkpoints to explore advanced tissue-level repartitioning and bioenergetics:
* **Selective ERRα and ERRγ Agonism:** SLU-PP-332 binds directly to the orphan nuclear receptors Estrogen-Related Receptor Alpha ($ERR\alpha$) and Estrogen-Related Receptor Gamma ($ERR\gamma$). This engagement activates a transcriptomic network that essentially mimics the exact cellular signals typically triggered by intensive endurance exercise or fasting protocols.
* **Mitochondrial Biogenesis & PGC-1α Upregulation:** The compound upregulates the transcription of Peroxisome proliferator-activated receptor gamma coactivator 1-alpha ($PGC\text{-}1\alpha$). This master regulator drives the synthesis of high-density mitochondrial networks within skeletal muscle and white adipose arrays, modeling the cellular mechanics of active tissue browning.
* **Upregulation of Lipid Beta-Oxidation:** By stimulating the expression of Carnitine Palmitoyltransferase-1 ($CPT\text{-}1$) and pyruvate dehydrogenase kinase 4 ($PDK4$), the matrix accelerates the transfer of long-chain fatty acids into the mitochondria. This shifts cellular preference toward continuous lipid oxidation ($ \beta\text{-oxidation} $) while preserving local glycogen stores.
* **Skeletal Muscle Fiber Repartitioning:** At the tissue level, SLU-PP-332 signaling promotes a structural shift toward oxidative, fatigue-resistant Type I (slow-twitch) muscle fiber characteristics. This adaptation is tracked for its capacity to maximize cellular oxygenation kinetics and support lean muscle mass retention during simulated caloric deficits.
### Research Applications
In preclinical and in vitro laboratory models, SLU-PP-332 Capsules 250mcg configurations are actively utilized to investigate:
* Exercise-mimicry signaling cascades, white adipose tissue browning, and systemic energy expenditure adaptations.
* Intracellular ERRalpha/ERRgamma receptor saturation, PGC-1alpha transcription, and high-density mitochondrial biogenesis.
* Skeletal muscle fiber repartitioning metrics, enhanced cellular respiration curves, and oxygen consumption rates ($OCR$).
* Safe, non-stimulatory fat mobilization parameters and lean tissue preservation during continuous weight-loss modeling.
Our SLU-PP-332 Capsules are precision-manufactured under strict laboratory quality control guidelines to ensure absolute ingredient standardization, uncompromised molecular stability, and dependable experimental reproducibility across every research batch.
—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*
